MX2009007765A - Derivados de azabiciclo-octano, el metodo de obtenerlos y sus usos como inhibidores de la dipeptidil-peptidasa iv. - Google Patents

Derivados de azabiciclo-octano, el metodo de obtenerlos y sus usos como inhibidores de la dipeptidil-peptidasa iv.

Info

Publication number
MX2009007765A
MX2009007765A MX2009007765A MX2009007765A MX2009007765A MX 2009007765 A MX2009007765 A MX 2009007765A MX 2009007765 A MX2009007765 A MX 2009007765A MX 2009007765 A MX2009007765 A MX 2009007765A MX 2009007765 A MX2009007765 A MX 2009007765A
Authority
MX
Mexico
Prior art keywords
inhibitors
derivatives
making
dipeptidyl peptidase
azabicyclo octane
Prior art date
Application number
MX2009007765A
Other languages
English (en)
Spanish (es)
Inventor
Li Li
Zhigang Lin
Fuqiang Zhao
Pengcho Tang
Hejun Lue
Original Assignee
Shanghai Hengrui Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Hengrui Pharm Co Ltd filed Critical Shanghai Hengrui Pharm Co Ltd
Publication of MX2009007765A publication Critical patent/MX2009007765A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
MX2009007765A 2007-01-23 2007-10-30 Derivados de azabiciclo-octano, el metodo de obtenerlos y sus usos como inhibidores de la dipeptidil-peptidasa iv. MX2009007765A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNA2007100043308A CN101230058A (zh) 2007-01-23 2007-01-23 双环氮杂烷类衍生物、其制备方法及其在医药上的用途
PCT/CN2007/070990 WO2008089636A1 (en) 2007-01-23 2007-10-30 Derivatives of azabicyclo octane, the method of making them and the uses thereof as inhibitors of dipeptidyl peptidase iv

Publications (1)

Publication Number Publication Date
MX2009007765A true MX2009007765A (es) 2009-07-30

Family

ID=39644101

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2009007765A MX2009007765A (es) 2007-01-23 2007-10-30 Derivados de azabiciclo-octano, el metodo de obtenerlos y sus usos como inhibidores de la dipeptidil-peptidasa iv.

Country Status (11)

Country Link
US (1) US8178575B2 (enExample)
EP (1) EP2133077B1 (enExample)
JP (1) JP5424256B2 (enExample)
KR (1) KR101482159B1 (enExample)
CN (2) CN101230058A (enExample)
AU (1) AU2007345133B8 (enExample)
BR (1) BRPI0719650A2 (enExample)
CA (1) CA2673164C (enExample)
MX (1) MX2009007765A (enExample)
RU (1) RU2447063C2 (enExample)
WO (1) WO2008089636A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2712352C (en) * 2008-01-23 2016-05-10 Jiangsu Hansoh Pharmaceutical Co., Ltd. Dicycloazaalkane derivates, preparation processes and medical uses thereof
CN101919851B (zh) * 2009-06-09 2012-02-08 江苏恒瑞医药股份有限公司 治疗哺乳动物包括人2型糖尿病的药物组合物
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2582709B1 (de) 2010-06-18 2018-01-24 Sanofi Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013091539A1 (zh) * 2011-12-21 2013-06-27 江苏恒瑞医药股份有限公司 吡咯并六元杂芳环类衍生物、其制备方法及其在医药上的应用
CN102827064B (zh) * 2012-08-14 2014-01-29 华东师范大学 一种氮杂双环[3.3.0]辛烷衍生物的合成方法
CN102827063B (zh) * 2012-08-14 2014-06-25 华东师范大学 一种氮杂双环[3.3.0]辛烷衍生物的合成方法
CN103709150B (zh) * 2012-10-09 2017-06-30 江苏豪森药业集团有限公司 托西酸贝格列汀晶型及其制备方法和用途
IN2015DN03795A (enExample) 2012-10-24 2015-10-02 Inserm Inst Nat De La Santé Et De La Rech Médicale
US9540324B2 (en) 2013-09-26 2017-01-10 Luc Therapeutics, Inc. Selective octahydro-cyclopenta[C] pyrrole negative modulators of NR2B
US10426818B2 (en) 2015-03-24 2019-10-01 Inserm (Institut National De La Sante Et De La Recherche Medicale) Method and pharmaceutical composition for use in the treatment of diabetes
JP6937828B2 (ja) 2016-11-23 2021-09-22 江蘇恒瑞医薬股▲ふん▼有限公司 ピロロ６員複素芳香環誘導体の製造方法、および中間体
CN111491920B (zh) * 2017-10-20 2024-01-30 范德比尔特大学 毒蕈碱性乙酰胆碱受体m4的拮抗剂
US11352344B2 (en) 2017-10-31 2022-06-07 Vanderbilt University Antagonists of the muscarinic acetylcholine receptor M4
SG11202005563YA (en) 2017-12-15 2020-07-29 Praxis Biotech LLC Inhibitors of fibroblast activation protein
CA3090130A1 (en) 2018-02-02 2019-08-08 Vanderbilt University Antagonists of the muscarinic acetylcholine receptor m4
JP2022514352A (ja) 2018-12-21 2022-02-10 プラクシス バイオテック エルエルシー 線維芽細胞活性化タンパク質の阻害剤
CN111620816B (zh) * 2020-05-27 2023-06-02 上海赛默罗生物科技有限公司 螺桨烷类衍生物、其制备方法、药物组合物和用途

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5280028A (en) * 1992-06-24 1994-01-18 G. D. Searle & Co. Benzimidazole compounds
US5736550A (en) * 1994-05-18 1998-04-07 Nisshin Flour Milling Co., Ltd. Pyrimidine derivatives
TW492957B (en) 1996-11-07 2002-07-01 Novartis Ag N-substituted 2-cyanopyrrolidnes
US6110949A (en) 1999-06-24 2000-08-29 Novartis Ag N-(substituted glycyl)-4-cyanothiazolidines, pharmaceutical compositions containing them and their use in inhibiting dipeptidyl peptidase-IV
US6395767B2 (en) * 2000-03-10 2002-05-28 Bristol-Myers Squibb Company Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and method
HUP0200849A2 (hu) * 2002-03-06 2004-08-30 Sanofi-Synthelabo N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
TW200401635A (en) * 2002-07-23 2004-02-01 Yamanouchi Pharma Co Ltd 2-Cyano-4-fluoropyrrolidine derivative or salt thereof
CA2517888C (en) * 2003-03-14 2012-05-01 Ono Pharmaceutical Co., Ltd. Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
GB0307856D0 (en) 2003-04-04 2003-05-14 Novartis Ag Organic compounds
CA2521271C (en) * 2003-04-04 2011-01-04 Novartis Ag Quinoline-2-one-derivatives for the treatment of airways diseases
US7288563B2 (en) * 2004-02-19 2007-10-30 Bristol-Myers Squibb Company Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity
US7381738B2 (en) * 2004-02-19 2008-06-03 Bristol-Myers Squibb Company Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity
US20070270417A1 (en) * 2004-07-22 2007-11-22 Glaxo Group Limited Antibacterial Agents
WO2006028961A2 (en) * 2004-09-03 2006-03-16 Athersys, Inc. Tricyclic heteroaryl piperazines, pyrrolidines and azetidines as serotonin receptor modulators
CN101050194B (zh) 2006-04-05 2013-08-21 上海恒瑞医药有限公司 双环辛烷类衍生物、其制备方法及其在医药上的用途

Also Published As

Publication number Publication date
CN101914092B (zh) 2012-12-26
JP2010516635A (ja) 2010-05-20
WO2008089636A1 (en) 2008-07-31
CN101230058A (zh) 2008-07-30
AU2007345133A1 (en) 2008-07-31
KR20090108093A (ko) 2009-10-14
AU2007345133B8 (en) 2013-05-02
EP2133077B1 (en) 2014-08-13
RU2447063C2 (ru) 2012-04-10
CA2673164A1 (en) 2008-07-31
RU2009124304A (ru) 2011-02-27
US8178575B2 (en) 2012-05-15
AU2007345133B2 (en) 2013-02-21
US20100016314A1 (en) 2010-01-21
HK1117164A1 (en) 2009-01-09
CN101914092A (zh) 2010-12-15
BRPI0719650A2 (pt) 2013-12-10
EP2133077A4 (en) 2010-12-22
JP5424256B2 (ja) 2014-02-26
CA2673164C (en) 2016-05-10
EP2133077A1 (en) 2009-12-16
KR101482159B1 (ko) 2015-01-13

Similar Documents

Publication Publication Date Title
MX2009007765A (es) Derivados de azabiciclo-octano, el metodo de obtenerlos y sus usos como inhibidores de la dipeptidil-peptidasa iv.
TW200614988A (en) Novel dipeptidyl peptidase iv inhibitors, pharmaceutical compositions containing them, and process for their preparation
GEP20094679B (en) Dipeptidyl peptidase inhibitors
WO2009117676A3 (en) Novel piperidine derivatives as inhibitors of stearoyl-coa desaturase
GEP20125652B (en) cMET INHIBITORS
MY150787A (en) Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of prevention of diabetes
MX2010009416A (es) Compuestos heterociclicos como inhibidores de cxcr2.
MX2009008264A (es) Compuestos espiro heterociclicos.
WO2007035629A3 (en) Process for the preparation of pyrimidinedione derivatives
ATE522518T1 (de) Indazol- und isoindolderivate als glucokinaseaktivierende stoffe
MX2012004210A (es) Derivados de pirazol como moduladores del canal de calcio activado por liberacion de calcio.
MX2008012490A (es) Aminotetrahidropiranos como inhibidores de dipeptidil peptidasa-iv para el tratamiento o prevencion de diabetes.
TW200724542A (en) Dipeptidyl peptidase-IV inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
TW200616623A (en) Organic compounds
MY152749A (en) Pyrazole and fused pyrazole glucokinase activators
MX2011001679A (es) Derivados de flavina.
TW200611898A (en) Organic compounds
UA94417C2 (ru) Замещенные 7-азаиндазолы, композиция, которая их содержит, и применение
MX2010001754A (es) Derivados de azepina como inhibidores de gamma secretasa.
TW200745067A (en) Novel compounds
MY152048A (en) 1-phenyl-2-pyridinyl alkyl alcohol derivatives as phosphodiesterase inhibitors
WO2008116107A3 (en) Piperazine derivatives as glucokinase activators
MX2010007927A (es) Derivados de 4-(pirrolo[2,3-c]piridin-3-il)pirimidin-2-ilamina.
IL189544A0 (en) Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
EA011572B9 (ru) Производные хинолина для применения в качестве микобактериальных ингибиторов

Legal Events

Date Code Title Description
FG Grant or registration